Trials / Unknown
UnknownNCT03167775
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- BeiJing Yijiayi Medicine Techonoloy Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
Detailed description
Patients with advanced primary liver cancer will be enrolled in the trial , then the patients will be treated with the Elemene Injection/Elemene Oral Emulusion in Combination with the best supportive treatment .The purpose of the study is to evaluate the effect and safety of the Elemene Injection/Elemene Oral Emulusion in Combination with the best supportive treatment in the treatment of advanced primary liver cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Elemene Injection/Elemene Oral Emulusion |
Timeline
- Start date
- 2016-11-28
- Primary completion
- 2019-05-27
- Completion
- 2019-11-27
- First posted
- 2017-05-30
- Last updated
- 2017-05-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03167775. Inclusion in this directory is not an endorsement.